NCT05031910 Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
| NCT ID | NCT05031910 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Thomas Jefferson University |
| Condition | Head and Neck Squamous Cell Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2022-02-04 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2022-02-04 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial studies the use of virtual reality technology and three dimensional surgery (3D-surgery) modeling to enhance current treatments in head and neck cancer surgery. Virtual reality 3D-surgery modeling may improve quality of surgical planning and interdisciplinary communication between surgeons and pathologists during the treatment of head and neck squamous cell cancer and ultimately increase the accuracy of planning, the quality of communication, and maximize the outcome patients with head and neck cancer experience throughout treatment.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with cancer of the head and neck (oral cavity, oropharynx, larynx, hypopharynx, T1-T4) * Receiving treatment at Thomas Jefferson University - Center City by a fellowship-trained HNC surgeon * Eligible for definitive resection * Age \> 18 * Provide signed written informed consent document Exclusion Criteria: * Impaired judgement or those unable to provide informed consent * Any factor that would place the patient at increased risk or preclude the individual's full compliance with or completion of the study * Nasopharyngeal carcinoma * Contraindications for surgery * Enrollment in other clinical trial
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05031910 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head and Neck Squamous Cell Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05031910 currently recruiting?
Yes, NCT05031910 is actively recruiting participants. Contact the research team at joseph.curry@jefferson.edu for enrollment information.
Where is the NCT05031910 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT05031910 clinical trial?
NCT05031910 is sponsored by Thomas Jefferson University. The trial plans to enroll 160 participants.